Your browser doesn't support javascript.
loading
Resting state EEG power spectrum and functional connectivity in autism: a cross-sectional analysis.
Garcés, Pilar; Baumeister, Sarah; Mason, Luke; Chatham, Christopher H; Holiga, Stefan; Dukart, Juergen; Jones, Emily J H; Banaschewski, Tobias; Baron-Cohen, Simon; Bölte, Sven; Buitelaar, Jan K; Durston, Sarah; Oranje, Bob; Persico, Antonio M; Beckmann, Christian F; Bougeron, Thomas; Dell'Acqua, Flavio; Ecker, Christine; Moessnang, Carolin; Charman, Tony; Tillmann, Julian; Murphy, Declan G M; Johnson, Mark; Loth, Eva; Brandeis, Daniel; Hipp, Joerg F.
Afiliação
  • Garcés P; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland. pilar.garces@roche.com.
  • Baumeister S; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Mason L; Department of Psychological Sciences, Centre for Brain and Cognitive Development, Birkbeck, University of London, London, UK.
  • Chatham CH; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
  • Holiga S; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
  • Dukart J; Institute of Neuroscience and Medicine, Brain and Behaviour (INM-7), Research Centre Jülich, Jülich, Germany.
  • Jones EJH; Medical Faculty, Institute of Systems Neuroscience, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Banaschewski T; Department of Psychological Sciences, Centre for Brain and Cognitive Development, Birkbeck, University of London, London, UK.
  • Baron-Cohen S; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Bölte S; Department of Psychiatry, Autism Research Centre, University of Cambridge, Cambridge, UK.
  • Buitelaar JK; Department of Women's and Children's Health, Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Karolinska Institutet and Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
  • Durston S; Curtin Autism Research Group, Curtin School of Allied Health, Curtin University, Perth, WA, Australia.
  • Oranje B; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
  • Persico AM; Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Beckmann CF; Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bougeron T; Interdepartmental Program "Autism 0-90", "G. Martino" University Hospital, University of Messina, Messina, Italy.
  • Dell'Acqua F; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
  • Ecker C; Human Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, Université de Paris, Paris, France.
  • Moessnang C; Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
  • Charman T; Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
  • Tillmann J; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, Goethe University, Frankfurt am Main, Germany.
  • Murphy DGM; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Johnson M; Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
  • Loth E; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
  • Brandeis D; Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
  • Hipp JF; Department of Psychological Sciences, Centre for Brain and Cognitive Development, Birkbeck, University of London, London, UK.
Mol Autism ; 13(1): 22, 2022 05 18.
Article em En | MEDLINE | ID: mdl-35585637

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Autístico / Transtorno do Espectro Autista Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Autístico / Transtorno do Espectro Autista Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article